Neuromyelitis Optica Testing and Treatment: Availability and Affordability in 60 Countries

ConclusionsThere is a gap in access to diagnostic testing for NMO in non-high-income countries, even in countries where acute and immunosuppressive treatment for NMO are available.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research